- Home
- PMEC vs GNTA Comparison
PMEC vs GNTA Comparison
Compare PMEC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- GNTA
- Stock Information
- Founded
- PMEC 1984
- GNTA 2014
- Country
- PMEC Singapore
- GNTA Italy
- Employees
- PMEC N/A
- GNTA N/A
- Industry
- PMEC
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMEC
- GNTA Health Care
- Exchange
- PMEC Nasdaq
- GNTA Nasdaq
- Market Cap
- PMEC 56.9M
- GNTA 62.9M
- IPO Year
- PMEC 2023
- GNTA 2021
- Fundamental
- Price
- PMEC $1.87
- GNTA $2.95
- Analyst Decision
- PMEC
- GNTA Strong Buy
- Analyst Count
- PMEC 0
- GNTA 1
- Target Price
- PMEC N/A
- GNTA $25.00
- AVG Volume (30 Days)
- PMEC 244.2K
- GNTA 16.8K
- Earning Date
- PMEC 01-01-0001
- GNTA 01-01-0001
- Dividend Yield
- PMEC N/A
- GNTA N/A
- EPS Growth
- PMEC N/A
- GNTA N/A
- EPS
- PMEC N/A
- GNTA N/A
- Revenue
- PMEC $74,349,000.00
- GNTA N/A
- Revenue This Year
- PMEC N/A
- GNTA N/A
- Revenue Next Year
- PMEC N/A
- GNTA N/A
- P/E Ratio
- PMEC N/A
- GNTA N/A
- Revenue Growth
- PMEC 2.52
- GNTA N/A
- 52 Week Low
- PMEC $0.54
- GNTA $2.56
- 52 Week High
- PMEC $1.89
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- PMEC 62.47
- GNTA 34.44
- Support Level
- PMEC $1.76
- GNTA $2.56
- Resistance Level
- PMEC $1.88
- GNTA $3.69
- Average True Range (ATR)
- PMEC 0.15
- GNTA 0.32
- MACD
- PMEC 0.02
- GNTA -0.07
- Stochastic Oscillator
- PMEC 96.92
- GNTA 20.10
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.